Oramed Pharmaceuticals In...
2.35
-0.01 (-0.42%)
At close: Jan 15, 2025, 3:59 PM
2.34
-0.21%
After-hours Jan 15, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Revenue 1.34M 2.70M 2.70M 2.71M 2.70M 2.45M 2.46M 641.00K n/a n/a n/a 184.25K 197.41K n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a 90.00K 90.00K 86.00K 187.00K 490.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit 1.34M 2.70M 2.70M 2.62M 2.61M 2.36M 2.27M 151.00K n/a n/a n/a 184.25K 197.41K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -15.77M -40.60M -24.22M -11.76M -14.63M -13.53M -10.77M -10.01M -7.38M -5.91M -4.30M 2.88M -2.44M -2.97M -2.78M -2.68M -3.13M -412.88K -44.81K -720.00K -50.00K
Interest Income 8.03M 3.57M 347.00K 690.00K 1.06M 903.00K 785.00K 474.00K 168.00K 225.00K 18.73K 13.13K 33.23K 24.69K 38.60K -83.19K -11.00K 1.99K n/a n/a n/a
Pretax Income 5.09M -37.66M -22.99M -11.51M -14.05M -12.73M -10.08M -9.63M -7.23M -5.69M -4.44M -3.25M -1.59M -2.96M -2.76M 2.61M -3.24M -414.58K -45.78K -720.00K -50.00K
Net Income 5.53M -37.76M -22.24M -11.51M -14.36M -12.73M -10.48M -10.96M -7.23M -5.70M -4.23M -3.34M -1.56M -2.98M -2.76M -2.77M -3.24M -414.58K -45.78K -720.00K -50.00K
Selling & General & Admin 8.14M 15.66M 5.94M 4.23M 3.72M 4.08M 2.76M 2.45M 2.60M 2.63M 2.03M 1.20M 1.28M 1.51M 1.26M 1.50M 918.00K 215.13K 44.81K 280.00K 50.00K
Research & Development 8.97M 27.64M 20.99M 10.23M 13.52M 11.98M 10.28M 7.71M 4.78M 3.28M 2.27M 1.68M 1.16M 1.46M 1.52M 1.18M 2.21M 197.75K n/a n/a 10.00K
Other Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 440.00K -10.00K
Operating Expenses 17.11M 43.30M 26.93M 14.47M 17.24M 16.06M 13.04M 10.16M 7.38M 5.91M 4.30M 2.88M 2.44M 2.97M 2.78M 2.68M 3.13M 412.88K 44.81K 720.00K 50.00K
Interest Expense 3.58M n/a n/a n/a n/a n/a n/a n/a n/a 11.00K 313.45K 199.12K 18.78K 14.54K 17.55K 10.28K -3.24M 3.68K -44.81K n/a n/a
Selling & Marketing Expenses -287.00K 1.85M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 17.11M 43.30M 26.93M 14.47M 17.33M 15.98M 13.23M 10.65M 7.38M 5.91M 4.30M 2.88M 2.44M 2.97M 2.78M 2.68M 3.13M 412.88K 44.81K 720.00K 50.00K
Income Tax n/a 100.00K -2.88M 192.00K 300.00K -800.00K 400.00K 1.33M -1K 4.00K -205.06K 90.22K -23.98K 14.97K -2.60K 162.16K 3.24M 414.58K 45.78K n/a n/a
Shares Outstanding (Basic) 40.32M 39.00M 28.47M 20.53M 17.45M 14.88M 13.31M 12.62M 10.82M 9.24M 7.21M 5.88M 5.42M 4.78M 4.72M 4.05M 3.52M 2.78M 1.54M 2.54M 2.90M
Shares Outstanding (Diluted) 40.57M 39.00M 28.47M 20.53M 17.45M 14.88M 13.31M 12.62M 10.82M 9.24M 7.21M 5.88M 5.42M 4.78M 4.72M 4.05M 3.52M 2.78M 1.54M 2.54M 2.90M
EPS (Basic) 0.14 -0.97 -0.78 -0.56 -0.82 -0.86 -0.79 -0.87 -0.67 -0.62 -0.59 -0.57 -0.29 -0.62 -0.58 -0.68 -0.92 -0.15 -0.03 -0.28 -0.02
EPS (Diluted) 0.14 -0.97 -0.78 -0.56 -0.82 -0.86 -0.79 -0.87 -0.67 -0.62 -0.59 -0.57 -0.29 -0.62 -0.58 -0.68 -0.92 -0.15 -0.03 -0.28 -0.02
EBITDA -15.57M -36.98M -25.04M -11.31M -14.17M -13.49M -10.76M -9.99M -7.38M -5.67M -4.13M -2.86M -2.37M -2.92M -2.72M -2.66M -3.02M -412.88K -44.81K -720.00K -50.00K
Depreciation & Amortization 196.00K 3.62M 77.00K 7.00K 8.00K 6.00K 5.00K 4.00K 4.00K 6.00K 5.38K 14.74K 28.30K 31.86K 30.49K 15.45K 108.00K -1.69K -973 n/a n/a